Govt cancels registration of popular cosmetic product over misleading claims
The cancellation underscores the regulator’s strict stance against misleading cosmetic claims
The cancellation underscores the regulator’s strict stance against misleading cosmetic claims
Relmada expects to initiate its Phase 3 program in the first half of 2026
The projected business potential is around US$ 1 million in the first year
This registration authorizes Nureca Technologies to continue manufacturing and exporting asuite of medical devices to the United States
Such combined efficacy (achieving clinical cure and microbiologic cure) of Zaynich is highest ever among all the FDA-approved novel antibiotics developed in the last more than 10 years
MoCRA mandates that all facilities involved in the manufacturing and processing of cosmetic products for sale in the United States
Shilpa Biologicals has developed high concentration adalimumab (100 mg/mL)
Patients visiting OPD sections of hospitals use their Ayushman Bharat Health Account (ABHA) to get instant tokens to save time spent in registration queues
The company has secured 506 marketing approvals for its oncology products across 76 countries.
Subscribe To Our Newsletter & Stay Updated